Excess moisture insurance coverage levels in Manitoba increasing for 2023 crop year

Oct 06, 2022

Manitoba producers will receive higher Excess Moisture Insurance (EMI) coverage levels as part of the AgriInsurance program for the 2023 crop year, federal Agriculture and Agri-Food Minister Marie-Claude Bibeau and Manitoba Agriculture Minister Derek Johnson announced today.

Basic EMI coverage is a standard feature of the AgriInsurance program that provides protection against the inability to seed due to wet conditions. Producers can choose increased coverage options at higher premiums. Since 2000, basic EMI coverage has been $50 per acre, while higher coverage options increased in 2014 to $75, and $100 per acre. For 2023, basic coverage will increase to $75 with higher coverage options increasing to $100 and $125.

These changes were made in consultation with producer groups that have expressed interest in higher coverage levels due to rising costs of farming. The province’s share of premiums for the 2023 EMI program is estimated to be $8.6 million.

MASC will send EMI confirmation letters to all existing AgriInsurance clients later this month to reflect the new coverage levels and premiums. Producers have until November 30 to make changes to their EMI coverage for 2023 by contacting a MASC Service Centre.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.